ConductScience.org, home

Paper40649226

Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions.

Iacob Ciobotaru S and 9 others. Molecules, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions. Papers, record 40649226. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40649226

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions.
PubMed
Journal
Molecules
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.61, provisional
iCite
Revised in PubMed
2025-07-14
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iacob Ciobotaru SSimona
2Stefan CSClaudia-Simona
3Nechita AAurel
4Matei MNMadalina-Nicoleta
5Lisa ELElena-Lacramioarahttps://orcid.org/0000-0001-9310-9731
6Tutunaru DDana
7Fulga IIuliu
8Fulga AAna
9Cristea Hohota AGAlina-Georgianahttps://orcid.org/0000-0001-9985-5057
10Dragostin OMOana-Maria

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PyrimidinesMajor topic
PurinesMajor topic
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Humans
Animals

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
7969/31.03.2025"Dunărea de Jos University of Galați"PubMed

Source PubMed

Download CSV of grants

References114

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136707808Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy.BMC Cancer2023https://conductscience.org/library/papers/36707808PubMed
230667505Breast Cancer Treatment: A Review.JAMA2019https://conductscience.org/library/papers/30667505PubMed
311888330Cellular and clinical pharmacology of fludarabine.Clin Pharmacokinet2002https://conductscience.org/library/papers/11888330PubMed
415763604Capecitabine: a review.Clin Ther2005https://conductscience.org/library/papers/15763604PubMed
523060388Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry.Environ Health Perspect2012https://conductscience.org/library/papers/23060388PubMed
624190492Purvalanol A is a strong apoptotic inducer via activating polyamine catabolic pathway in MCF-7 estrogen receptor positive breast cancer cells.Mol Biol Rep2014https://conductscience.org/library/papers/24190492PubMed
729642417Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis.Int J Mol Sci2018https://conductscience.org/library/papers/29642417PubMed
833305635Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?Expert Opin Drug Discov2021https://conductscience.org/library/papers/33305635PubMed
917627520Molecular hybridization: a useful tool in the design of new drug prototypes.Curr Med Chem2007https://conductscience.org/library/papers/17627520PubMed
1033387732Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities.Bioorg Chem2021https://conductscience.org/library/papers/33387732PubMed
1131566975Hydration of Aromatic Heterocycles as an Adversary of π-Stacking.J Chem Inf Model2019https://conductscience.org/library/papers/31566975PubMed
1221242742Cladribine: mode of action and implications for treatment of multiple sclerosis.Clin Neuropharmacol2011https://conductscience.org/library/papers/21242742PubMed
1311114313Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.N Engl J Med2000https://conductscience.org/library/papers/11114313PubMed
1420722491Safety of capecitabine: a review.Expert Opin Drug Saf2010https://conductscience.org/library/papers/20722491PubMed
1526081925Purine Analogues as Kinase Inhibitors: A Review.Recent Pat Anticancer Drug Discov2015https://conductscience.org/library/papers/26081925PubMed
1635517208Synthesis and biological evaluation of dehydroabietic acid-pyrimidine hybrids as antitumor agents.RSC Adv2020https://conductscience.org/library/papers/35517208PubMed
174910304The crystal structures of purines, pyrimidines and their intermolecular complexes.Prog Nucleic Acid Res Mol Biol1970https://conductscience.org/library/papers/4910304PubMed
1840006082Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40006082PubMed
1932918216Epidemiology of Skin Cancer: Update 2019.Adv Exp Med Biol2020https://conductscience.org/library/papers/32918216PubMed
2025084222Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer.Eur J Pharmacol2014https://conductscience.org/library/papers/25084222PubMed

See all 114 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42513119Selected Thieno[2,3-d] Pyrimidine Derivatives Target Breast Cancer Cell Proliferation and Membrane Organization.Molecules2026https://conductscience.org/library/papers/42513119PubMed
42495331Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications.ACS Omega2026https://conductscience.org/library/papers/42495331PubMed
42105200Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000-2025).Med Res Rev2026https://conductscience.org/library/papers/42105200PubMed
41602180Thienopyrimidine scaffolds as promising antimicrobial agents: synthesis, biological evaluation, DFT analysis and molecular docking.RSC Adv2026https://conductscience.org/library/papers/41602180PubMed
41266472
Design, synthesis, and biological evaluation of novel 6-(4-aminopiperidin-1-yl)-substituted benzyl-3-methylpyrimidine-2,4(1H,3H)-dione derivatives as potential anticancer agents targeting thymidylate synthase.
Sci Rep2025https://conductscience.org/library/papers/41266472PubMed
41183108Novel pyrimidine-substituted chalcones: In vitro antioxidant properties and cytotoxic effects against human cancer cell lines.PLoS One2025https://conductscience.org/library/papers/41183108PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40649226

GET https://conductscience.org/api/papers/v1/40649226/references?page=2